Angiogenesis-independent tumor growth mediated by stem-like cancer cells PØ Sakariassen, L Prestegarden, J Wang, KO Skaftnesmo, ... Proceedings of the National Academy of Sciences 103 (44), 16466-16471, 2006 | 262 | 2006 |
The alarmin IL-33 is a notch target in quiescent endothelial cells E Sundlisæter, RJ Edelmann, J Hol, J Sponheim, AM Küchler, M Weiss, ... The American journal of pathology 181 (3), 1099-1111, 2012 | 89 | 2012 |
Targeting the notch signaling pathway in chronic inflammatory diseases PF Christopoulos, TT Gjølberg, S Krüger, G Haraldsen, JT Andersen, ... Frontiers in immunology 12, 668207, 2021 | 64 | 2021 |
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells J Pollheimer, J Bodin, O Sundnes, RJ Edelmann, SS Skånland, ... Arteriosclerosis, thrombosis, and vascular biology 33 (2), e47-e55, 2013 | 60 | 2013 |
Lymphangiogenesis in colorectal cancer—prognostic and therapeutic aspects E Sundlisæter, A Dicko, PØ Sakariassen, K Sondenaa, PØ Enger, ... International journal of cancer 121 (7), 1401-1409, 2007 | 58 | 2007 |
Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture U Rajcevic, JC Knol, S Piersma, S Bougnaud, F Fack, E Sundlisaeter, ... Proteome science 12, 1-14, 2014 | 51 | 2014 |
Inhibition of endothelial NOTCH1 signaling attenuates inflammation by reducing cytokine-mediated histone acetylation at inflammatory enhancers LC Poulsen, RJ Edelmann, S Krüger, R Diéguez-Hurtado, A Shah, ... Arteriosclerosis, thrombosis, and vascular biology 38 (4), 854-869, 2018 | 41 | 2018 |
Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation E Sundlisæter, J Wang, PØ Sakariassen, M Marie, JR Mathisen, ... Neuropathology and applied neurobiology 32 (4), 419-427, 2006 | 25 | 2006 |
Increased lymphatic vascular density is seen before colorectal cancers reach stage II and growth factor FGF‐2 is downregulated in tumor tissue compared with normal mucosa E Sundlisaeter, GV Røsland, JK Hertel, PØ Sakariassen, B Almås, ... Apmis 117 (3), 212-221, 2009 | 18 | 2009 |
Management of ocular manifestations of atopic dermatitis: a consensus meeting using a modified Delphi process JP Thyssen, S Heegaard, L Ivert, A Remitz, T Agner, M De Bruin-Weller, ... Acta dermato-venereologica 100 (16), 2020 | 13 | 2020 |
Antiangiogenic treatment of ocular diseases E Sundlisæter, C Tvedt Tidsskrift for Den norske legeforening, 2018 | 2 | 2018 |
Antibody blockade of Jagged1 attenuates choroidal neovascularization TT Gjølberg, JA Wik, H Johannessen, S Krüger, N Bassi, ... Nature Communications 14 (1), 3109, 2023 | 1 | 2023 |
Antiangiogen behandling av øyesykdommer E Sundlisæter, C Tvedt Tidsskrift for Den norske legeforening, 2018 | | 2018 |
Notch Enhances the Endothelial Inflammatory Response E Sundlisaeter, RJ Edelmann, J Hol, S Kruger, J Wang, M Kasprzycka, ... SCANDINAVIAN JOURNAL OF IMMUNOLOGY 79 (6), 425-425, 2014 | | 2014 |
Regulering av inflammasjon i karendotel HS Valeur Tidsskrift for Den norske legeforening, 2013 | | 2013 |
The Alarmin Interleukin-33 is a Notch Target in Quiescent Endothelial Cells (174.6) G Haraldsen, R Jetne, J Hol, J Sponheim, A Küchler, M Kasprzycka, ... The Journal of Immunology 188 (1_Supplement), 174.6-174.6, 2012 | | 2012 |
Komplikasjoner etter gastrokirurgiske operasjoner E Sundlisæter, O Mjåland Tidsskrift for Den norske legeforening, 2009 | | 2009 |
Complications after gastrointestinal surgery E Sundlisaeter, O Mjåland Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin, ny …, 2009 | | 2009 |
Anti-VEGF-behandling av aldersrelatert makuladegenerasjon E Sundlisæter, MS Sivertsen | | |